PRTA · Prothena Corp Public Ltd Co
$8.86
-0.22 (-2.42%)
At close · Aug 14
Market Cap
$454.85M
Shares
51.34M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Gene Kinney | President and Chief Executive Officer | $3,213,354 |
| Michael J. Malecek | Chief Legal Officer and Company Secretary | $2,289,017 |
| Tran Nguyen | Chief Operating Officer and Chief Financial Officer | $1,566,459 |
| Carol D. Karp | Chief Regulatory Officer | $1,083,583 |
| Radhika Tripuraneni | M.D., M.P.H. Chief Development Officer | $1,055,694 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Gene Kinney | President and Chief Executive Officer | $11,396,769 |
| Tran Nguyen | Chief Operating Officer and Chief Financial Officer | $4,957,233 |
| Carol D. Karp | Chief Regulatory Officer | $3,437,844 |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| Gene Kinney | President and Chief Executive Officer | $5,148,245 |
| Tran Nguyen | Chief Operating Officer and Chief Financial Officer | $3,260,717 |
| Carol D. Karp | Chief Regulatory Officer | $573,500 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Paula Cobb | Board of Directors | Resigned | 2025-12-12 |
| David A. Ford | Chief People Officer | Terminated | 2025-06-18 |
| Carol D. Karp | Chief Regulatory Officer | Terminated | 2025-06-18 |
| Oleg Nodelman | Board of Directors | Resigned | 2024-12-30 |
| Hideki Garren, M.D., Ph.D. | Chief Medical Officer | Resigned | 2024-09-27 |
| William H. Dunn, Jr., M.D. | director | Appointed | 2023-05-16 |
| Dr. Sanjiv K. Patel | Board of Directors | Resigned | 2023-04-28 |
| Helen S. Kim | director | Appointed | 2022-09-01 |
Key facts
CIK
1559053
CUSIP
G72800108
13F (30d)
181 filings
177 filers
Visit website
Investor relations